CYP2C19-genotype guided antiplatelet tx may be beneficial
(HealthDay)—Patients with a CYP2C19 loss-of-function allele have increased risk of major adverse cardiovascular events (MACE) with clopidogrel versus alternative antiplatelet therapy after percutaneous coronary intervention ...
Nov 3, 2017
0
0
